XOMA Announces Retirement of Fred Kurland and Appointment of Thomas Burns as Chief Financial Officer Mar 03, 2015 7:00am EST
XOMA to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Webcast on March 11 Feb 26, 2015 3:22pm EST
XOMA Announces Pricing of $40.0 Million Registered Offering of Common Stock and Warrants Dec 09, 2014 9:00am EST
XOMA Highlights Recent Achievements and Reports Financial Results for the Third Quarter of 2014 Nov 06, 2014 4:01pm EST
XOMA Initiates Pivotal Phase 3 Gevokizumab Study in Patients With Pyoderma Gangrenosum Nov 04, 2014 9:01am EST
